McKinsey & Co., Inc., National Prescription Opiate Consultant Litigation

Final Approval Granted

Judge Charles R Breyer granted final approval on February 2, 2024. A payment schedule will be posted soon.

---

A settlement has been reached in a class action lawsuit against McKinsey & Company, Inc.; McKinsey Holdings, Inc.; McKinsey & Company, Inc., United States; and McKinsey & Company, Inc., Washington, D.C., (“McKinsey”) claiming that McKinsey played a central role in the unfolding, propagation, and exploitation of the opioid crisis by advising multiple opioid manufacturers and other industry participants how to sell as many prescription opioids as possible. The lawsuit is known as In re McKinsey & Co., Inc., National Prescription Opiate Consultant Litigation, Case No. 3:21-md-02996-CRB (N.D. California). McKinsey denies Plaintiffs’ allegations.

IF YOU ARE A POLITICAL SUBDIVISION YOU MAY BE ENTITLED TO RECEIVE A PAYMENT FROM AN OPIOIDS CLASS ACTION SETTLEMENT.

Your Legal Rights and Options in This Settlement

Remain in the Class	No need to take any action to receive your share of the Settlement.
Object to the Settlement Deadline (Postmarked): January 5, 2024	If you stay in the Class, you may object to the Settlement. You may submit a timely written notice of objection to the Court.
Exclude Your Subdivision (Opt Out) Deadline: January 5, 2024	You may request to be excluded from the Settlement, and, if you do, you will receive no benefits from the Settlement.
Attend the Final Approval Hearing	If you object to the Settlement as described above, you may also ask to speak in Court about the fairness of the Settlement.